Pharmaceutical Company Disputes Insolvency Claims

  • Bausch Health shares rebound from 52-week low
  • Company disputes bankruptcy rumors
  • Shares touched 48% lower on both NYSE and TSX
  • Reorg’s report clarified as unsubstantiated

Shares of Bausch Health bounced back after a significant decline, following an article by Reorg suggesting the company was considering bankruptcy proceedings. The shares were trading at around US$6 and C$8.29 on the New York Stock Exchange (NYSE) and Toronto Stock Exchange (TSX), respectively. Prior to this, they had reached 52-week lows, dropping by up to 48% from Tuesday’s closes on both exchanges. A Reorg post, later reposted on their account, stated that Bausch Health hadn’t been involved in discussions with creditors regarding bankruptcy proceedings. The company called the report an ‘unsubstantiated rumor.’ Bausch Health owns about 89% of Bausch + Lomb’s outstanding shares.

Factuality Level: 7
Factuality Justification: The article provides accurate and objective information about Bausch Health’s response to a misleading report by Reorg, and includes relevant details about the company’s stock performance. However, it could be improved by providing more context on the original rumor and including quotes from Bausch Health or other sources.
Noise Level: 3
Noise Justification: The article provides relevant information about the company’s response to a rumor and its impact on stock prices but lacks in-depth analysis or new knowledge that the reader can apply.
Public Companies: Bausch Health (BHC), Bausch + Lomb (Not available)
Key People: Josh Beckerman (Author)


Financial Relevance: Yes
Financial Markets Impacted: New York Stock Exchange and Toronto Stock Exchange
Financial Rating Justification: The article discusses the impact of rumors on Bausch Health’s stock price and its effect on the financial markets, as well as the company’s statement disputing the bankruptcy report. It also mentions the shares having circuit breaker halts and volatility-related pauses.
Presence Of Extreme Event: Yes
Nature Of Extreme Event: Financial Crisis
Impact Rating Of The Extreme Event: Severe
Extreme Rating Justification: The article discusses a steep drop in the company’s shares, reaching 52-week lows and a potential bankruptcy rumor, which caused significant financial impact on the company and its shareholders.

Reported publicly: www.marketwatch.com